![]() The stock has gained 6.1% in the past month. (NASDAQ: AAPL) and increased the firm's price target to $175 per share from the previous $170. JPMorgan maintained an Overweight rating on Apple Inc. (NASDAQ: AAPL), emphasizing stellar Mac sales and strong iPhone 13 demand for the remainder of the year. JPMorgan analyst Samik Chatterjee is bullish on Apple Inc. In the third quarter, Apple Inc.'s (NASDAQ: AAPL) revenue totaled $81.4 billion, up 36% year over year and beating analysts' consensus of $73.14 billion. The Big Tech FAANGs climbed more than 0.6% each as the Nasdaq topped the other two major indices in the last five days. (NASDAQ: HCRX), a company that obtains royalties in the biopharmaceutical industry, has begun the roadshow for its initial public offering, as announced at the end of July 2021, with 46.9 million shares priced at $15 to $17 each, valuing the company at $3.4 billion. With the current pharma market boom, Healthcare Royalty, Inc. Shares of healthcare stocks like Johnson & Johnson (NYSE: JNJ), Novavax, Inc. The spread of the Delta variant has resurfaced, causing public concern, but it has helped the healthcare and utility sectors outperform in the last month. Likewise, the major indexes have rebounded impressively from recent setbacks, with the S&P 500, NASDAQ Composite Indexes, and Dow Jones Industrial Average gaining 18%, 16%, and 15%, respectively, year to date. According to the Commerce Department, the US GDP increased by 6.5% in the second quarter of 2021, exceeding its pre-pandemic level. Investors are gaining confidence to exit the bear market as the economy reopens due to rising vaccination rates, a low unemployment rate, and increased consumer confidence. If you want to skip our detailed analysis of these stocks, go directly to the 5 Popular Stocks to Buy Right Now. ![]() In this article, we discuss the 10 most popular stocks to buy right now.
0 Comments
Leave a Reply. |